Doctoral Researcher at the University of Helsinki, Finland | Life Sciences | Earn 3 639,84 € | Apply Now
In the high-stakes arena of neuro-oncology in 2026, Glioblastoma Multiforme (GBM) remains one of the most formidable challenges in medicine. However, the ImmunoViroTherapy Lab at the University of Helsinki is pioneering a breakthrough via the INTRABRAIN project. As a Doctoral Researcher, you won’t just be earning a degree; you will be at the forefront of a multidisciplinary effort to “arm” viruses to infiltrate and dismantle brain tumors from the inside out.
About The University
Founded in 1640, the University of Helsinki (UH) is not just Finland’s oldest and largest institution of academic education; it is a global research powerhouse currently ranked among the top 100 universities worldwide in 2026. For anyone pursuing a Life Sciences PhD, UH offers an environment where centuries of tradition meet the absolute bleeding edge of biotechnology. The Faculty of Pharmacy, where this Doctoral Researcher position is based, is a cornerstone of the university’s scientific output. It is the only independent faculty of pharmacy in Finland and a recognized leader in the ULLA consortium (the European University Consortium for Pharmaceutical Sciences).
The Lab & The Mission: INTRABRAIN 2026
The ImmunoViroTherapy Lab, led by Prof. Vincenzo Cerullo, is a world leader in developing customized “cancer vaccines” and viral platforms. This specific University of Helsinki PhD Vacancies listing is part of the INTRABRAIN Doctoral Network, a Horizon-MSCA initiative.
The goal? To revolutionise GBM treatment by bypassing the blood-brain barrier (BBB) using nanotechnology and intranasal delivery. As a Doctoral Researcher (DC 2), your specific focus will be the generation and optimization of armed oncolytic viruses, specifically recombinant Adenovirus variants encoding the immune-stimulating cytokine IL-12 (rADV-IL-12).
Key Responsibilities: Navigating your Life Sciences PhD
This Life Sciences PhD is designed for the modern researcher who thrives at the intersection of virology, immunology, and nanotechnology. Your work will bridge the gap between bench-side viral engineering and production-ready therapeutic systems.
- Viral Engineering: Generating novel rADV-IL-12 variants and optimizing their antigenic profiles.
- Efficacy Validation: Conducting rigorous in vitro and in vivo experiments to evaluate tumor killing and immune activation.
- Immune Profiling: Analyzing how the “armed” viruses alter the immunosuppressive microenvironment of GBM.
- Advanced Technology Integration: Through secondments in Italy, Spain, and France, you will gain expertise in Focused Ultrasound (FUS) and intranasal delivery strategies to enhance drug transport across the BBB.
- Scaling Up: Contributing to the transition of viral constructs from laboratory research to larger-scale production systems.
Candidate Profile For Doctoral Researcher
The Marie Skłodowska-Curie Actions (MSCA) have strict eligibility criteria designed to promote international mobility and early-career development.
- Mobility Rule: You must not have resided or worked in Finland for more than 12 months in the 3 years immediately prior to recruitment.
- Career Stage: You must be in the first four years of your research career and not yet hold a doctoral degree.
- Academic Foundation: A Master’s degree in Biotechnology, Molecular Biology, or Biomedical Engineering.
- Linguistic Skills: Proficiency in English is mandatory to thrive in this international consortium.
Compensation & The Helsinki Lifestyle
A University of Helsinki PhD Vacancy offers some of the most stable and competitive doctoral conditions in Europe and one of the best Doctoral Researcher positions.
- Living Allowance: Approximately 3,639.84 €/month (before taxes).
- Mobility Allowance: 546.15 €/month (plus potential family allowances).
- Environment: Finland repeatedly tops the World Happiness Report and offers high-quality healthcare, free schooling, and excellent expat support.
- Duration: 36 months of guaranteed funding via the European Commission.
- Deadline: 28th of May 2026
- Start Date: Negotiable from September 2026
In summary, this Doctoral Researcher position is a definitive Life Sciences PhD for those ready to lead in the 2026 biotech sector. You are joining an ambitious, interdisciplinary network that equips you with both high-level scientific expertise and transferable skills for a future in personalized cancer medicine. If you have a multidisciplinary background and a passion for “hacking” viruses to save lives, the University of Helsinki is looking for you.
